Elisabetta Tozzi

Prof. Elisabetta Tozzi

orcid

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2013 in The Journal of Headache and Pain
Verified
Journal Article
Open access
PDF file
BBBenedetta Bellini
Benedetta Bellini
MAMarco Antônio Arruda
Marco Antônio Arruda
ACAlessandra Cescut
Alessandra Cescut
CSCosetta Saulle
Cosetta Saulle
APAntonio M. Persico
Antonio M. Persico
Vincenzo GuidettiVincenzo Guidetti
Vincenzo Guidetti
Headache is one of the most common neurological symptom reported in childhood and adolescence, leading to high levels of school absences and being associated with several comorbid conditions, particularly in neurological, psychiatric and cardiovascular systems. Neurological and psychiatric disorders, that are associated with migraine, are mainly depression, anxiety disorders, epilepsy and sleep disorders, ADHD and Tourette syndrome. It also has been shown an association with atopic disease and cardiovascular disease, especially ischemic stroke and patent foramen ovale (PFO).

1 June 2003 in Epilepsy Research
Verified
Journal Article
Closed access
MEMonika Maria Eisermann
Monika Maria Eisermann
ADA. DeLaRaillère
A. DeLaRaillère
GDG. Dellatolas
G. Dellatolas
ETElisabetta Tozzi
Elisabetta Tozzi
RNR. Nabbout
R. Nabbout
CCC. Chiron
C. Chiron

29 May 2012 in European Journal of Neurology
Verified
Journal Article
Closed access
PDF file
AVA. Verrotti
A. Verrotti
SAS. Agostinelli
S. Agostinelli
CDC. D'EGidio
C. D'EGidio
AFA. Di Fonzo
A. Di Fonzo
Marco CarotenutoMarco Carotenuto
Marco Carotenuto
PBP. A. Battistella
P. A. Battistella

1 May 2011 in Epilepsy & Behavior
Verified
Journal Article
Closed access
AVAlberto Verrotti
Alberto Verrotti
Giangennaro CoppolaGiangennaro Coppola
Giangennaro Coppola
AFAlessia Di Fonzo
Alessia Di Fonzo
ETElisabetta Tozzi
Elisabetta Tozzi
ASAlberto Spalice
Alberto Spalice
PPPasquale Parisi
Pasquale Parisi

28 November 2007 in Developmental Medicine & Child Neurology
Verified
Journal Article
Open access
PDF file
AVAlberto Verrotti
Alberto Verrotti
CCCaterina Cerminara
Caterina Cerminara
Giangennaro CoppolaGiangennaro Coppola
Giangennaro Coppola
EFEmilio Franzoni
Emilio Franzoni
PPPasquale Parisi
Pasquale Parisi
PCPaolo Curatolo
Paolo Curatolo
The aim of this study was to evaluate the efficacy and tolerability of levetiracetam (LEV) monotherapy in juvenile myoclonic epilepsy (JME). The study group consisted of 32 patients with epilepsy (20 males, 12 females) with a mean age of 13 years 3 months (SD 7y 11mo) at seizure onset. LEV was administered as the first drug; all patients were followed up at 6 and 12 months. The dose that achieved seizure control ranged from 1000 to 2500mg/daily. At 6‐month evaluation: 15 patients were seizure free; 14 patients were responders (>50% reduction in seizures); and three patients had marginal effects (<50% reduction of seizures). At 12‐month evaluation: 29 patients were seizure free; three patients were responders. No patients reported adverse events. These data provide preliminary evidence that LEV may be effective for treating patients with newly diagnosed JME.

29 March 2011 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
AVAlberto Verrotti
Alberto Verrotti
Giangennaro CoppolaGiangennaro Coppola
Giangennaro Coppola
ASAlberto Spalice
Alberto Spalice
AFAlessia Di Fonzo
Alessia Di Fonzo
RBRaffaella Bruschi
Raffaella Bruschi
PPPasquale Parisi
Pasquale Parisi